全文获取类型
收费全文 | 2099篇 |
免费 | 25篇 |
国内免费 | 1篇 |
专业分类
电工技术 | 10篇 |
综合类 | 1篇 |
化学工业 | 106篇 |
金属工艺 | 5篇 |
机械仪表 | 9篇 |
建筑科学 | 17篇 |
能源动力 | 9篇 |
轻工业 | 94篇 |
水利工程 | 11篇 |
无线电 | 64篇 |
一般工业技术 | 69篇 |
冶金工业 | 1683篇 |
原子能技术 | 4篇 |
自动化技术 | 43篇 |
出版年
2022年 | 5篇 |
2021年 | 6篇 |
2020年 | 5篇 |
2019年 | 5篇 |
2018年 | 9篇 |
2015年 | 7篇 |
2014年 | 10篇 |
2013年 | 21篇 |
2012年 | 24篇 |
2011年 | 20篇 |
2010年 | 10篇 |
2009年 | 12篇 |
2008年 | 11篇 |
2007年 | 21篇 |
2006年 | 14篇 |
2005年 | 28篇 |
2004年 | 19篇 |
2003年 | 13篇 |
2002年 | 9篇 |
2001年 | 8篇 |
2000年 | 8篇 |
1999年 | 51篇 |
1998年 | 528篇 |
1997年 | 312篇 |
1996年 | 205篇 |
1995年 | 106篇 |
1994年 | 89篇 |
1993年 | 111篇 |
1992年 | 23篇 |
1991年 | 30篇 |
1990年 | 24篇 |
1989年 | 23篇 |
1988年 | 26篇 |
1987年 | 38篇 |
1986年 | 23篇 |
1985年 | 20篇 |
1984年 | 5篇 |
1982年 | 15篇 |
1981年 | 16篇 |
1980年 | 18篇 |
1979年 | 6篇 |
1978年 | 7篇 |
1977年 | 39篇 |
1976年 | 95篇 |
1975年 | 4篇 |
1973年 | 3篇 |
1970年 | 6篇 |
1969年 | 5篇 |
1968年 | 6篇 |
1967年 | 5篇 |
排序方式: 共有2125条查询结果,搜索用时 304 毫秒
1.
Bram H. Frohock Jessica M. Gilbertie Dr. Jennifer C. Daiker Dr. Lauren V. Schnabel Dr. Joshua G. Pierce 《Chembiochem : a European journal of chemical biology》2020,21(7):933-937
The failure of frontline antibiotics in the clinic is one of the most serious threats to human health and requires a multitude of novel therapeutics and innovative approaches to treatment so as to curtail the growing crisis. In addition to traditional resistance mechanisms resulting in the lack of efficacy of many antibiotics, most chronic and recurring infections are further made tolerant to antibiotic action by the presence of biofilms. Herein, we report an expanded set of 5-benzylidene-4-oxazolidinones that are able to inhibit the formation of Staphylococcus aureus biofilms, disperse preformed biofilms, and, in combination with common antibiotics, are able to significantly reduce the bacterial load in a robust collagen-matrix model of biofilm infection. 相似文献
2.
JJ Harris DK Lunt SB Smith WL Mies DS Hale M Koohmaraie JW Savell 《Canadian Metallurgical Quarterly》1997,75(4):986-992
Two groups of Brangus steers produced by nuclear transplantation cloning were used in parallel studies investigating the impact of calf- and yearling-feeding. The first group (n = 8) were fed as calves (CF; n = 4) or yearlings (YF; n = 4) to a constant age end point of 16 mo. The second group (n = 10) were fed as calves (CF; n = 5) or yearlings (YF; n = 5) to a constant live weight end point (530 kg). When slaughtered at the same age, CF and YF steers did not differ (P > .05) in feedlot ADG, but the CF steers were heavier and had higher dressing percentages, numeric yield grades, and quality grades (P < .05). Top loin steaks from the groups of steers did not differ (P > .05) in palatability traits. When fed to a constant live weight, the YF steers gained more rapidly (P < .05) and had lower (P < .05) numeric yield grades than did CF steers. Again CF steers had higher (P < .05) dressing percentages. There was no difference (P > .05) between the treatments in carcass quality grade or meat palatability characteristics. Thus, when finished to a constant weight end point, YF steers gained more rapidly, with no adverse effects on carcass quality grade or palatability traits; however, CF steers consistently produced higher dressing percentages, largely due to greater external fatness. 相似文献
3.
4.
SB McNeil 《Canadian Metallurgical Quarterly》1997,23(3):287-8; discussion 289-90, 317
Jehovah's Witnesses refuse blood transfusions for themselves and for their children. This action can be difficult for health professionals to understand and can lead to tensions between the staff and family. For one family, their refusal of blood for their child lead to a greater understanding of their religion and its beliefs for those who cared for them. Interspersed with their story are the medical reasons their son required blood, the reasons Jehovah's Witnesses refuse blood transfusions, and what the acceptable alternatives are to Jehovah's Witnesses. This article will share the thoughts and feelings of the family and the nursing staff who cared for the family during this crisis. 相似文献
5.
6.
7.
The majority of patients with soft tissue or bone sarcomas of the upper extremity can be treated today with limb-saving procedures using combined modality therapies. For patients with a tumor in the shoulder area, sometimes an interscapulothoracic amputation is the only radical surgical treatment. However, in selected cases, in which the tumor does not involve the neurovascular bundle, a limb-sparing alternative might be the Tikhoff-Linberg resection. Normal function of the hand and forearm, with reasonable function of the elbow, can be maintained by this procedure. Four case histories are reported. 相似文献
8.
9.
PURPOSE: To assess long-term survival following cladribine salvage treatment for previously treated patients with chronic lymphocytic leukemia. PATIENTS AND METHODS: Fifty-two patients aged 39-84 years with previously treated CLL received cladribine 0.12 mg/kg/day in 2-hour infusions for 5 days in monthly courses. Two-thirds were refractory to previous therapy, and 8 had prior fludarabine. RESULTS: Sixteen (31%) patients achieved complete response (CR) and 14 (27%) partial remission (PR) according to consensus criteria. Response correlated with clinical stage, number of previous treatment regimes, blood lymphocyte count, and lymphocyte halflife following the first cladribine course. Toxicity included pneumonia (n = 9), herpes zoster (n = 7), and septicemia (n = 2). Four patients in CR underwent high-dose chemotherapy with autologous blood stem cell support, and 2 remain in CR 48 and 60 months from start of cladribine, and 2 had relapse at 42 and 48 months, respectively. Median progression-free survival (Kaplan-Meier analysis) for CR patients was 23 months from start of cladribine treatment, and for PR patients 16 months. The projected overall survival was 80% at 3 years for CR patients, and the median survival 28 months for PR patients and 4 months for non-responding patients. CONCLUSIONS: Our previous finding of durable CRs from cladribine in advanced CLL is thus confirmed in a larger patient material, and follow-up indicate that long-term survival may be achieved. 相似文献
10.
Socially amoral economic forces now drive health system change. The authors, assisted by a panel of experts on employers, health plans, providers, and consumers, discuss current drivers such as (1) employers' price-focused purchasing, without good quality/value measures; (2) health plans' growing successes and market clout; (3) providers declining prospects and fears about their future; and (4) consumers' worries about less choice. Future influences will include Medicare reforms, better information, and pro-consumer regulation of managed care, as well as rising social distress. The health system's future is now open for resolution in an evolving, imperfect market. 相似文献